What was corrected and how
A subsequent correction by the company to the contents of an already published filing.
Notice Regarding the Execution of a Basic Agreement for the Full Subsidiarization of 株式会社IMGホールディングス
2. Overview of the Company Acquiring the Shares: ⑼ Major Shareholders and Ownership Ratios
株式会社 Medical Management Consulting (representative director Yasui Hirotsugu (安井 浩倫)) 91.00% / Yasui Hirotomo (安井 浩倫) 6.00% / Utsunomiya Yuki (宇都宮 由生) 2.00% / Sugiyama Ryota (杉山 亮太) 1.00%
As of 1 August 2025 株式会社スマイル・オン 16.10% / 株式会社トライユニティ 16.10% / Tasaka Daisaku (田坂 大作) 13.00％ / Imamura Go (今村 豪) 13.00% / Imamura Kai (今村 海) 11.90% / Yasui Hirotomo (安井 浩倫) 6.00% / Tasaka Nao (田坂 菜央) 4.70% / Tasaka Kota (田坂 凰太) 4.70% / 有限会社オーティーエヌ 4.50％ / Tasaka Masaki (田坂 将貴) 2.00% / Imamura Riku (今村 陸) 2.00% / Utsunomiya Yuki (宇都宮 由生) 2.00% / Sugiyama Ryota (杉山 亮太) 1.00% / Ono Yohei (小野 洋平) 1.00% / As of 1 September 2025 株式会社 Medical Management Consulting (representative director Yasui Hirotsugu (安井 浩倫)) 91.00% / Yasui Hirotomo (安井 浩倫) 6.00% / Utsunomiya Yuki (宇都宮 由生) 2.00% / Sugiyama Ryota (杉山 亮太) 1.00% / As of 3 September 2025 株式会社 Medical Management Consulting (representative director Yasui Hirotsugu (安井 浩倫)) 91.00% / Yasui Hirotomo (安井 浩倫) 3.80% / Utsunomiya Yuki (宇都宮 由生) 2.00% / Sugiyama Ryota (杉山 亮太) 1.00% / 20 other individuals 2.20% / As of 28 November 2025 株式会社 Medical Management Consulting (representative director Yasui Hirotsugu (安井 浩倫)) 24.44% / 株式会社スマイル・オン 15.13% / 株式会社トライユニティ 15.13% / Yasui Hirotomo (安井 浩倫) 8.27% / 有限会社オーティーエヌ 4.23% / Utsunomiya Yuki (宇都宮 由生) 1.88% / Sugiyama Ryota (杉山 亮太) 0.94% / 34 other individuals 29.98%
As announced in the "Notice Regarding the Publication of the Independent Investigation Committee's Final Investigation Report" dated 10 August 2026, the independent investigation committee's final investigation report revealed that a temporary transfer of shares in IMGホールディングス had been carried out and that, although the shareholder composition was scheduled to be restored to its previous composition before this share exchange, only the temporary shareholder composition had been disclosed. This disclosure is therefore being corrected.
| Item | Details |
|---|---|
| Disclosure subject to correction | Notice Regarding the Execution of a Basic Agreement for the Full Subsidiarization of 株式会社IMGホールディングス |
| Original disclosure date | 10 September 2025 |
| Location of correction | 2. Overview of the Company Acquiring the Shares: ⑼ Major Shareholders and Ownership Ratios |
| Details of correction | 株式会社 Medical Management Consulting (representative director Yasui Hirotsugu (安井 浩倫)) 91.00% / Yasui Hirotomo (安井 浩倫) 6.00% / Utsunomiya Yuki (宇都宮 由生) 2.00% / Sugiyama Ryota (杉山 亮太) 1.00% → As of 1 August 2025 株式会社スマイル・オン 16.10% / 株式会社トライユニティ 16.10% / Tasaka Daisaku (田坂 大作) 13.00％ / Imamura Go (今村 豪) 13.00% / Imamura Kai (今村 海) 11.90% / Yasui Hirotomo (安井 浩倫) 6.00% / Tasaka Nao (田坂 菜央) 4.70% / Tasaka Kota (田坂 凰太) 4.70% / 有限会社オーティーエヌ 4.50％ / Tasaka Masaki (田坂 将貴) 2.00% / Imamura Riku (今村 陸) 2.00% / Utsunomiya Yuki (宇都宮 由生) 2.00% / Sugiyama Ryota (杉山 亮太) 1.00% / Ono Yohei (小野 洋平) 1.00% / As of 1 September 2025 株式会社 Medical Management Consulting (representative director Yasui Hirotsugu (安井 浩倫)) 91.00% / Yasui Hirotomo (安井 浩倫) 6.00% / Utsunomiya Yuki (宇都宮 由生) 2.00% / Sugiyama Ryota (杉山 亮太) 1.00% / As of 3 September 2025 株式会社 Medical Management Consulting (representative director Yasui Hirotsugu (安井 浩倫)) 91.00% / Yasui Hirotomo (安井 浩倫) 3.80% / Utsunomiya Yuki (宇都宮 由生) 2.00% / Sugiyama Ryota (杉山 亮太) 1.00% / 20 other individuals 2.20% / As of 28 November 2025 株式会社 Medical Management Consulting (representative director Yasui Hirotsugu (安井 浩倫)) 24.44% / 株式会社スマイル・オン 15.13% / 株式会社トライユニティ 15.13% / Yasui Hirotomo (安井 浩倫) 8.27% / 有限会社オーティーエヌ 4.23% / Utsunomiya Yuki (宇都宮 由生) 1.88% / Sugiyama Ryota (杉山 亮太) 0.94% / 34 other individuals 29.98% |
| Reason for correction | As announced in the "Notice Regarding the Publication of the Independent Investigation Committee's Final Investigation Report" dated 10 August 2026, the independent investigation committee's final investigation report revealed that a temporary transfer of shares in IMGホールディングス had been carried out and that, although the shareholder composition was scheduled to be restored to its previous composition before this share exchange, only the temporary shareholder composition had been disclosed. This disclosure is therefore being corrected. |
Items this document does not state (1)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The independent investigation committee's final investigation report revealed that a temporary transfer of shares had been carried out and that, although the shareholder composition was scheduled to be restored to its previous composition before the share exchange, only the temporary shareholder composition had been disclosed.